Buetti N. et al.
Local signs at insertion site and catheter-related bloodstream infections: an observational post hoc analysis using individual data of four RCTs.
Crit. Care. 2020 Dec 14 |
Berçot B. et al.
High Prevalence and High Rate of Antibiotic Resistance of Mycoplasma genitalium Infections in Men who Have Sex with Men. A Sub-Study of the ANRS Ipergay PrEP Trial.
Clin. Infect. Dis. 2020 Dec 11 |
Le Hingrat Q. et al.
Detection of SARS-CoV-2 N-antigen in blood during acute COVID-19 provides a sensitive new marker and new testing alternatives.
Clin. Microbiol. Infect. 2020 Dec 8 |
Buetti N. et al.
Ultrasound guidance and risk for central venous catheter-related infections in the ICU. A post hoc analysis of individual data of three multi-centric randomized trials.
Clin. Infect. Dis. 2020 Dec 5 |
Lecuru M. et al.
Emergence of Imipenem Resistance in a CpxA-H208P-Variant-Producing Proteus mirabilis Clinical Isolate.
Microb. Drug Resist. 2020 Nov 24 |
Peiffer-Smadja N. et al.
How and why do French medical students choose the specialty of infectious and tropical diseases? A national cross-sectional study.
BMC Med. Educ. 2020 Oct 31 |
Galardini M. et al.
Major role of iron uptake systems in the intrinsic extra-intestinal virulence of the genus Escherichia revealed by a genome-wide association study.
PLoS Genet. 2020 Oct 28 |
Castry M. et al.
Impact of test-and-treat and risk reduction strategies on HCV transmission among MSM living with HIV in France: a modelling approach.
Gut 2020 Oct 27 |
Gonçalves A. et al.
What drives the dynamics of HBV RNA during treatment?
J. Viral Hepat. 2020 Oct 19 |
Yazdanpanah Y. et al.
Impact on disease mortality of clinical, biological and virological characteristics at hospital admission and over time in COVID-19 patients.
J. Med. Virol. 2020 Oct 15 |
Sibiude J. et al.
Risk of birth defects and perinatal outcomes in HIV-infected women exposed to integrase strand inhibitors during pregnancy.
AIDS 2020 Oct 8 |
Hobson C.A. et al.
KPC beta-lactamases are permissive to insertions and deletions conferring substrate spectrum modifications and resistance to ceftazidime-avibactam.
Antimicrob. Agents Chemother. 2020 Oct 5 |
Duprilot M. et al.
Success of Escherichia coli O25b:H4 ST131 clade C associated with a decrease in virulence.
Infect. Immun. 2020 Sep 28 |
Isernia V. et al.
SARS-COV2 infection in 30 HIV-infected patients followed-up in a French University Hospital.
Int. J. Infect. Dis. 2020 Sep 25 |
Bailly S. et al.
Impact of loading dose of caspofungin in PK/PD target attainment for severe candidiasis infections in ICU patients – the CASPOLOAD study.
Antimicrob. Agents Chemother. 2020 Sep 21 |
Massot M. et al.
Temporal dynamics of the fecal microbiota in veal calves in a 6-month field trial.
Animal Microbiome 2020 Sep 15 |
Petit M. et al.
Rapid detection and characterization of carbapenemases in Enterobacterales with a new modified carbapenem inactivation method: mCIMplus.
J. Clin. Microbiol. 2020 Sep 2 |
Fontaine C. et al.
Relationship between the composition of the intestinal microbiota and the tracheal and intestinal colonization by opportunistic pathogens in intensive care patients.
PLoS One. 2020 Aug 28 |
Denamur E. et al.
The population genetics of pathogenic Escherichia coli.
Nat. Rev. Microbiol. 2020 Aug 21 |
Grzelak L. et al.
A comparison of four serological assays for detecting anti-SARS-CoV-2 antibodies in human serum samples from different populations.
Sci. Transl. Med. 2020 Aug 17 |
Rodrigues C. et al.
Community-acquired infection caused by the uncommon hypervirulent Klebsiella pneumoniae ST66-K2 lineage.
Microb. Genom. 2020 Aug 4 |
Hobson C.A. et al.
Urine zinc concentrations allow proper expression of metallo-β-lactamases in Enterobacteriaceae.
J. Antimicrob. Chemother. 2020 Jul 25 |
Atlani-Duault L. et al.
France’s COVID-19 response: balancing conflicting public health traditions.
Lancet 2020 Jul 25 |
Poline J. et al.
Systematic SARS-CoV-2 screening at hospital admission in children: a French prospective multicenter study.
Clin. Infect. Dis. 2020 Jul 25 |
Maisonnasse P. et al.
Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates.
Nature 2020 Jul 22 |
Lê M.P. et al.
Pharmacokinetics of lopinavir/ritonavir oral solution to treat COVID-19 in mechanically ventilated ICU patients.
J. Antimicrob. Chemother. 2020 Jul 20 |
Canovas J. et al.
Expression of CTX-M-15 limits the efficacy of ceftolozane/tazobactam against Escherichia coli in a high-inoculum murine peritonitis model.
Clin. Microbiol. Infect. 2020 Jul 2 |
Ouldali N. et al.
Emergence of Kawasaki disease related to SARS-CoV-2 infection in an epicentre of the French COVID-19 epidemic: a time-series analysis.
Lancet Child Adolesc. Health 2020 Jul 2 |
Peiffer-Smadja N. et al.
Performance and impact of a multiplex PCR in ICU patients with ventilator-associated pneumonia or ventilated hospital-acquired pneumonia.
Crit. Care 2020 Jun 19 |
Gonçalves A. et al.
Timing of antiviral treatment initiation is critical to reduce SARS-CoV-2 viral load.
CPT Pharmacometrics Syst. Pharmacol. 2020 Jun 18 |
Kemble H. et al.
Flux, toxicity, and expression costs generate complex genetic interactions in a metabolic pathway.
Science Advances 2020 Jun 3 |
Lê M.P. et al.
Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial.
J. Antimicrob. Chemother. 2020 May 30 |
Roujansky A. et al.
Analysis of paradoxical efficacy of carbapenems against carbapenemase-producing Escherichia coli in a murine model of lethal peritonitis.
Antimicrob. Agents Chemother. 2020 May 18 |
de Lastours V. et al.
Mortality in Escherichia coli bloodstream infections: antibiotic resistance still does not make it.
J. Antimicrob. Chemother. 2020 May 17 |
Jacquier H. et al.
Molecular epidemiology of Neisseria gonorrhoeae clinical isolates in Reunion and Mayotte.
Sex. Transm. Infect. 2020 May 4 |
Deslandes A. et al.
SARS-CoV-2 was already spreading in France in late december 2019.
Int. J. Antimicrob. Agents 2020 May 3 |
Delory T. et al.
A Computerized Decision Support System (CDSS) for antibiotic prescription in primary care-antibioclic: implementation, adoption and sustainable Use in the era of extended antimicrobial resistance.
J. Antimicrob. Chemother. 2020 May 1 |
Visseaux B. et al.
Evaluation of the QIAstat-Dx respiratory SARS-CoV-2 panel, the first rapid multiplex PCR commercial assay for SARS-CoV-2 detection.
J. Clin. Microbiol. 2020 Apr 27 |
Andremont O. et al.
Semi-quantitative cultures of throat and rectal swabs are efficient tests to predict ESBL-Enterobacterales ventilator-associated pneumonia in mechanically ventilated ESBL carriers.
Intensive Care Med. 2020 Apr 20 |
Jouvin-Marche E. et al.
French research strategy to tackle antimicrobial resistance.
Lancet 2020 Apr 18 |
Caméléna F. et al.
Genomic characterization of 16S rRNA methyltransferase-producing Escherichia coli isolates from the Parisian area, France.
J. Antimicrob. Chemother. 2020 Apr 16 |
Sallard E. et al.
Type 1 interferons as a potential treatment against COVID-19.
Antiviral Res. 2020 Apr 7 |
Lescure FX. et al.
Clinical and virological data of the first cases of COVID-19 in Europe: a case series.
Lancet Infect. Dis. 2020 Mar 27 |
Madelain V. et al.
Modeling favipiravir antiviral efficacy against emerging viruses: from animal studies to clinical trials.
CPT Pharmacometrics Syst. Pharmacol. 2020 Mar 20 |
Choudhury A. et al.
CRISPR/Cas9 recombineering-mediated deep mutational scanning of essential genes in Escherichia coli.
Mol. Syst. Biol. 2020 Mar 16 |
Marcelin AG. et al.
Frequency of capsid substitutions associated with GS-6207 in vitro resistance in HIV-1 from antiretroviral-naive and -experienced patients.
J. Antimicrob. Chemother 2020 Mar 10 |
Cointe A. et al.
Escherichia coli O80 hybrid pathotype strains producing Shiga toxin and ESBL: molecular characterization and potential therapeutic options.
J. Antimicrob. Chemother. 2020 Mar 1 |
Charpentier C. et al.
Pharmacovirological analyses of blood and male genital compartment in patients receiving dolutegravir + lamivudine dual therapy as a switch strategy (ANRS 167 LAMIDOL trial).
J. Antimicrob. Chemother. 2020 Feb 24 |
Riglet F. et al.
Bayesian individual dynamic predictions with uncertainty of longitudinal biomarkers and risks of survival events in a joint modelling framework: a comparison between Stan, Monolix, and NONMEM.
AAPS J. 2020 Feb 19 |
Peiffer-Smadja N. et al.
Machine learning in the clinical microbiology laboratory: has the time come for routine practice?
Clin. Microbiol. Infect. 2020 Feb 12 |
Hobson CA et al.
Impact of anticancer chemotherapy on the extension of beta-lactamase spectrum: an example with KPC-type carbapenemase activity towards ceftazidime-avibactam.
Sci. Rep. 2020 Jan 17 |
Tubiana S. et al.
Community-acquired bacterial meningitis in adults: in-hospital prognosis, long term disability and determinants of outcome in a multicentre prospective cohort.
Clin. Microbiol. Infect. 2020 Jan 9 |
Le Hingrat Q. et al.
Genetic variability of long terminal repeat region between HIV-2 groups impacts transcriptional activity.
J. Virol. 2020 Jan 8 |